NYSE
According to Zyberno, EQUIFAX INC (EFX) is not a buy — AVERAGE BUSINESS (59/100) with a negative Margin of Safety of +6.7% and a Brina Gap of -16.4% showing the market already prices in more growth than the fundamentals support.
According to Zyberno's DCF model, EQUIFAX INC (EFX) trades at $194.41 against an estimated intrinsic value per share of $208.43 — a +6.7% Margin of Safety based on Owner Earnings of $1.14B TTM, projected at 12.2% growth for 10 years with a 2.5% terminal growth rate. The Brina Gap of -16.4% weakens the case: based on the company's ROIC (8.5%) and reinvestment rate (-20.8%), the business can fundamentally grow at -1.8% — but the current enterprise value implies the market expects 14.6%. This places EFX in the Expensive Hype quadrant of the Brina Matrix, the most fragile combination — overvalued on cash AND overpriced on growth. Zyberno's model translates this into a 5-year expected return of 13.7% annually.
Over the trailing twelve months, EFX generated $1.14B in Owner Earnings. Capital was deployed as follows: $260.00M returned via share buybacks, $256.20M paid as dividends, $494.60M invested in capital expenditures. Reinvestment rate: -20.8%. Owner Earnings have grown at 12.2% annually over the trailing five years using log-linear regression.